Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Clin Genitourin Cancer. 2020 Oct 14;19(2):144–154. doi: 10.1016/j.clgc.2020.10.002

Figure 1.

Figure 1

Survival by Histology and Receipt of NAC. (A) OS in Institutional Cohort, Stratified by Histology. (B) RFS in Institutional Cohort, Stratified by Histology. (C) OS in Institutional Cohort of Patients With cT2-4 MPC, Stratified by NAC Receipt. (D) OS in SEER-Medicare Cohort of Patients With cT2-4 MPC, Stratified by NAC Receipt. *Exact Counts Masked in Compliance With Centers for Medicare and Medicaid Services/Surveillance, Epidemiology, and End Results (CMS/SEER) Publication Policy of No Counts With < 11 Cases

Abbreviations: CUC = conventional urothelial carcinoma; MPC = micropapillary urothelial carcinoma; NAC = neoadjuvant chemotherapy; OS = overall survival; RC = radical cystectomy; RFS = recurrence-free survival.